Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

ENFIELD, Conn. — Saint Francis Hospital is partnering with Enfield Emergency Medical Services to allow whole blood to be ...

It's typically the most watched television event of the year, and this year's Super Bowl is expected to be no exception. The ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Long-term exposure to certain air pollutants significantly increased risk for venous thromboembolism, according to results of ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.CcrFU5Zy.js ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...

Recently published article reviews paediatric patient blood management (PBM) which has transitioned from a blood ...